A study revealed that IBD patients, particularly those with ulcerative colitis and multiple biologic treatments, face an ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...

Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulated cell death for immune mediated ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...

To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...

Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...

Bengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global ...

Equillium and Biocon announce positive data from phase 2 study of itolizumab to treat moderate to severe ulcerative colitis: Our Bureau, Bengaluru Friday, February 7, 2025, 10:30 ...

Inflammatory bowel diseases (IBDs), which include ulcerative colitis (UC) and Crohn’s disease (CD), are chronic conditions ...

Collagenous colitis and lymphocytic colitis, the two main subtypes of microscopic colitis, may develop as a result of an immune response. This could happen when something causes the body to ...

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affects the large intestine, causing persistent inflammation in the colon and rectum. The condition typically begins in the ...